Loading...

Fund Overview

Fund Size

Fund Size

₹18 Cr

Expense Ratio

Expense Ratio

0.22%

ISIN

ISIN

INF194KB1IS2

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

06 Sep 2024

About this fund

This fund has been in existence for 2 months and 28 days, having been launched on 06-Sep-24.
As of 03-Dec-24, it has a Net Asset Value (NAV) of ₹10.17, Assets Under Management (AUM) of 17.62 Crores, and an expense ratio of 0.22%.
  • The fund's asset allocation comprises around 100.06% in equities, 0.00% in debts, and -0.06% in cash & cash equivalents.
  • You can start investing in Bandhan BSE Healthcare Index Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Portfolio Summaryas of 31st October 2024

Equity17.63 Cr100.06%
Others-0.01 Cr-0.06%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity2.72 Cr15.45%
Cipla LtdEquity1.18 Cr6.70%
Dr Reddy's Laboratories LtdEquity1.06 Cr6.01%
Divi's Laboratories LtdEquity1.02 Cr5.81%
Max Healthcare Institute Ltd Ordinary SharesEquity1.02 Cr5.81%
Apollo Hospitals Enterprise LtdEquity0.95 Cr5.41%
Lupin LtdEquity0.72 Cr4.09%
Aurobindo Pharma LtdEquity0.54 Cr3.04%
Fortis Healthcare LtdEquity0.44 Cr2.52%
Alkem Laboratories LtdEquity0.41 Cr2.35%
Torrent Pharmaceuticals LtdEquity0.4 Cr2.26%
Mankind Pharma LtdEquity0.36 Cr2.07%
Glenmark Pharmaceuticals LtdEquity0.35 Cr1.96%
Zydus Lifesciences LtdEquity0.34 Cr1.95%
Ipca Laboratories LtdEquity0.29 Cr1.65%
Laurus Labs LtdEquity0.26 Cr1.50%
Suven Pharmaceuticals LtdEquity0.23 Cr1.30%
Piramal Pharma LtdEquity0.22 Cr1.27%
Syngene International LtdEquity0.21 Cr1.21%
Abbott India LtdEquity0.21 Cr1.18%
Biocon LtdEquity0.19 Cr1.09%
J.B. Chemicals & Pharmaceuticals LtdEquity0.19 Cr1.08%
Krishna Institute of Medical Sciences LtdEquity0.18 Cr1.03%
Gland Pharma LtdEquity0.18 Cr1.01%
Ajanta Pharma LtdEquity0.18 Cr1.01%
Natco Pharma LtdEquity0.17 Cr0.97%
Neuland Laboratories LimitedEquity0.17 Cr0.97%
Dr. Lal PathLabs LtdEquity0.16 Cr0.89%
GlaxoSmithKline Pharmaceuticals LtdEquity0.15 Cr0.86%
Concord Biotech LtdEquity0.15 Cr0.83%
Strides Pharma Science LtdEquity0.14 Cr0.82%
Aster DM Healthcare Ltd Ordinary SharesEquity0.14 Cr0.77%
Poly Medicure LtdEquity0.14 Cr0.77%
Global Health LtdEquity0.13 Cr0.71%
Jubilant Pharmova LtdEquity0.12 Cr0.70%
Wockhardt LtdEquity0.12 Cr0.69%
Narayana Hrudayalaya LtdEquity0.12 Cr0.66%
Granules India LtdEquity0.11 Cr0.64%
Rainbow Childrens Medicare LtdEquity0.11 Cr0.63%
Pfizer LtdEquity0.11 Cr0.60%
Eris Lifesciences Ltd Registered ShsEquity0.09 Cr0.49%
Alembic Pharmaceuticals LtdEquity0.08 Cr0.48%
Sanofi India LtdEquity0.08 Cr0.47%
Marksans Pharma LtdEquity0.08 Cr0.46%
Metropolis Healthcare LtdEquity0.07 Cr0.43%
Jupiter Life Line Hospitals LtdEquity0.07 Cr0.39%
AstraZeneca Pharma India LtdEquity0.06 Cr0.37%
Vijaya Diagnostic Centre LtdEquity0.06 Cr0.36%
Ami Organics LtdEquity0.06 Cr0.36%
Shilpa Medicare LtdEquity0.06 Cr0.35%
Procter & Gamble Health LtdEquity0.06 Cr0.32%
Caplin Point Laboratories LtdEquity0.06 Cr0.32%
Glenmark Life Sciences LtdEquity0.04 Cr0.25%
Aarti Pharmalabs LtdEquity0.04 Cr0.24%
Net Current AssetsCash-0.04 Cr0.23%
Morepen Laboratories LtdEquity0.04 Cr0.21%
FDC LtdEquity0.04 Cr0.21%
Indegene LtdEquity0.03 Cr0.20%
Kovai Medical Center & Hospital LtdEquity0.03 Cr0.20%
Advanced Enzyme Technologies LtdEquity0.03 Cr0.18%
Orchid Pharma LtdEquity0.03 Cr0.17%
Sun Pharma Advanced Research Co LtdEquity0.03 Cr0.17%
Triparty Repo Trp_041124Cash - Repurchase Agreement0.03 Cr0.17%
Sequent Scientific LtdEquity0.03 Cr0.17%
Solara Active Pharma Sciences Ltd Ordinary SharesEquity0.03 Cr0.16%
Yatharth Hospital and Trauma Care Services LtdEquity0.03 Cr0.14%
HealthCare Global Enterprises LtdEquity0.02 Cr0.14%
Indraprastha Medical Corp LtdEquity0.02 Cr0.14%
Krsnaa Diagnostics LtdEquity0.02 Cr0.13%
Unichem Laboratories LtdEquity0.02 Cr0.13%
Aarti Drugs LtdEquity0.02 Cr0.13%
Supriya Lifescience LtdEquity0.02 Cr0.12%
Hikal LtdEquity0.02 Cr0.11%
Thyrocare Technologies LtdEquity0.02 Cr0.11%
Dishman Carbogen Amics LtdEquity0.02 Cr0.10%
Innova Captab LtdEquity0.02 Cr0.09%
Gufic Biosciences LtdEquity0.02 Cr0.09%
Blue Jet Healthcare LtdEquity0.02 Cr0.09%
Indoco Remedies LtdEquity0.02 Cr0.09%
RPG Life Sciences LtdEquity0.01 Cr0.08%
IOL Chemicals And Pharmaceuticals LtdEquity0.01 Cr0.07%
Syncom Formulation (India) LtdEquity0.01 Cr0.07%
Hester Biosciences LtdEquity0.01 Cr0.07%
Gujarat Themis Biosyn LtdEquity0.01 Cr0.07%
SMS Pharmaceuticals LtdEquity0.01 Cr0.07%
Windlas Biotech LtdEquity0.01 Cr0.07%
Bliss GVS Pharma LtdEquity0.01 Cr0.06%
Artemis Medicare Services Ltd Ordinary SharesEquity0.01 Cr0.06%
Suven Life Sciences LtdEquity0.01 Cr0.06%
Kopran LtdEquity0.01 Cr0.06%
Sigachi Industries LtdEquity0.01 Cr0.06%
Themis Medicare LtdEquity0.01 Cr0.06%
Novartis India LtdEquity0.01 Cr0.06%
Shalby LtdEquity0.01 Cr0.05%
Lincoln Pharmaceuticals LtdEquity0.01 Cr0.05%
Tarsons Products LtdEquity0.01 Cr0.05%
GPT Healthcare LtdEquity0.01 Cr0.04%
Vimta Labs LtdEquity0.01 Cr0.03%
NGL Fine-Chem LtdEquity0 Cr0.03%
KMC Speciality Hospitals (India) LtdEquity0 Cr0.02%
Sastasundar Ventures LtdEquity0 Cr0.02%
Cash Margin - CcilCash - Repurchase Agreement0 Cr0.00%

Allocation By Market Cap (Equity)

Large Cap Stocks

45.66%

Mid Cap Stocks

28.50%

Small Cap Stocks

24.93%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare17.36 Cr98.55%
Basic Materials0.1 Cr0.54%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

--

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

--

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

--

Higher the better

Fund Managers

Nemish Sheth

Nemish Sheth

Since September 2024

Additional Scheme Detailsas of 31st October 2024

ISIN
INF194KB1IS2
Expense Ratio
0.22%
Exit Load
No Charges
Fund Size
₹18 Cr
Age
2 months
Lumpsum Minimum
₹1,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund nameExpense RatioExit LoadFund size
1Y
ICICI Prudential Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹565.80 Cr-
ICICI Prudential Nifty Midcap 150 Index Fund Regular Growth

Very High Risk

0.9%0.0%₹565.80 Cr-
ICICI Prudential Nifty 200 Momentum 30 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹471.41 Cr-
SBI Nifty Midcap 150 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹670.31 Cr-
DSP Nifty 50 Equal Weight Index Fund Regular Growth

Very High Risk

0.9%0.0%₹1886.93 Cr-
SBI Nifty Smallcap 250 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹1190.98 Cr-
SBI Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹670.31 Cr-
ICICI Prudential Nifty 200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹471.41 Cr-
DSP Nifty 50 Equal Weight Index Fund Direct Growth

Very High Risk

0.4%0.0%₹1886.93 Cr-
SBI Nifty Smallcap 250 Index Fund Regular Growth

Very High Risk

1.0%0.0%₹1190.98 Cr-

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Bandhan BSE Healthcare Index Fund Direct Growth, as of 03-Dec-2024, is ₹10.17.
The fund's allocation of assets is distributed as 100.06% in equities, 0.00% in bonds, and -0.06% in cash and cash equivalents.
The fund managers responsible for Bandhan BSE Healthcare Index Fund Direct Growth are:-
  1. Nemish Sheth